Laurus Labs Ltd share price logo

Laurus Labs Ltd

NSE: LAURUSLABS

BSE: 540222

Mid Cap

Pharma Sector

₹1878.50

-48.40

(-2.51%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Block Deal Alert

Laurus Labs Limited saw an NSE block trade of approximately 430,164 shares valued at Rs. 80.64 crore at Rs. 1874.60 per share.

What are INDmoney investors doing with Laurus Labs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-5%

Searches for Laurus Labs on INDmoney have decreased by 5% over the last 30 days.

Investment activity on INDmoney

-10.63%

Investment activity in Laurus Labs among INDmoney users has decreased by 10.63% over the last 30 days.

Among the most traded stocks

33rd

Laurus Labs was the 33rd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

22 days

INDmoney investors hold Laurus Labs shares for an average of 22 days.

Key Events for Laurus Labs

Last Dividend Declared

₹1.20 per share, declared on 30/04/2026

View Dividend History

Laurus Labs Stock Performance

as on September 16, 2026 at 6:26 pm IST

  • Day's Low

    Day's High

    ₹1,863.50
    ₹1,940.40
    downward going graph

    0.80%

    Downside

    3.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹823.10
    ₹1,981.80
    downward going graph

    56.18%

    Downside

    5.50%

    Upside

    downward going graph

Laurus Labs share price movements today

Previous Close
₹1,926.90
Open
₹1,877.50
Volume
20.33L
Upper Circuit
₹2,119.50
Lower Circuit
₹1,734.30
Day's Low - High
₹1,863.50 - ₹1,940.40
52 Week Low - High
₹823.10 - ₹1,981.80

Laurus Labs Historical Returns

1 Month Return
+ 6.48 %
3 Month Return
+ 40 %
1 Year Return
+ 115.33 %
3 Year Return
+ 389.43 %
5 Year Return
+ 196.54 %

Laurus Labs Fundamentals

as on September 16, 2026 at 12:56 pm IST

Market Cap

₹1,04,112.76 Cr

Return on Equity (ROE)

15.09

PE Ratio (TTM)

97.19

Return on capital employed (ROCE)

14.95

Industry PE ratio

51.81

Beta (LTM)

0.84

P/B Ratio

10.19

Dividend Yield

0.2

PEG Ratio

8.98

Quarterly Earnings Growth YOY

124.73

EPS (TTM)

16.48

Book Value

98.18

Laurus Labs Stock Valuation

as on September 16, 2026 at 12:56 pm IST

Laurus Labs in the last 5 years

  • Overview

  • Trends

Lowest (16.96x)

March 28, 2023

Industry (51.81x)

September 11, 2026

Today (97.19x)

September 11, 2026

Highest (242.70x)

December 6, 2024

LowHigh

Today’s Price to Earnings Ratio: 97.19x

Laurus Labs Technical Analysis

Track how Laurus Labs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish9
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.17
Bullish
CCI (20)
587.03
Bearish
RSI (14)
52.94
Neutral
Momentum (10)
-1.3
Bearish
ADI (14)
16.93
Neutral
Ultimate Oscillator (7,14,28)
25.65
Bearish

Moving Averages

Name

Value

Action

SMA (20)
1876.6
Bullish
EMA (20)
1876.56
Bullish
VWMA (20)
1876.35
Bullish
SMA (50)
1877.06
Bullish
EMA (50)
1876.25
Bullish
SMA (200)
1872.72
Bullish
EMA (200)
1880.28
Bearish
KAMA (200)
1875.21
Bullish
DEMA (200)
1866.83
Bullish

Laurus Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Laurus Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD1,04,112.7639.31%0.698896,812
Dr Lal Pathlabs Ltd image
Dr Lal Pathlabs Ltd
BUY31,998.70-1.37%0.545092,762
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
BUY61,707.506.64%0.602,35314,712
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY14,869.7824.83%0.66172814
Thyrocare Technologies Ltd image
Thyrocare Technologies Ltd
BUY8,665.765.62%0.55162829
See all

Market expectation of Laurus Labs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

41.67%

Buy

25.00%

Hold

33.33%

Sell

Laurus Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,224.45
1,194.92
1,439.67
1,194.91
1,223.7
1,415.05
1,720.3
1,569.57
1,653.47
1,778.29
1,811.57
2,026.31
Other Income
1.78
2.43
18.53
2.51
4.6
9.42
58.57
10.43
26.96
5.76
11.8
9.18
Total Income
1,226.23
1,197.35
1,458.2
1,197.42
1,228.3
1,424.47
1,778.87
1,580
1,680.43
1,784.05
1,823.37
2,035.49
Expenses
1,036.58
1,013.5
1,198.18
1,023.71
1,045.37
1,129.9
1,299.7
1,187.44
1,250.21
1,298.08
1,299.46
1,388.04
Operating Profit
187.87
181.42
241.49
171.2
178.33
285.15
420.6
382.13
403.26
480.21
512.11
638.27
Operating Profit Margin %
15.34%
15.18%
16.77%
14.33%
14.57%
20.15%
24.45%
24.35%
24.39%
27%
28.27%
31.5%
Profit Before Interest, Tax and Depreciation
189.65
183.85
260.02
173.71
182.93
294.57
479.17
392.56
430.22
485.97
523.91
647.45
Interest
42.39
50.82
50.5
49.19
52.61
57.8
56.4
51.5
40
38.79
40.44
42.22
Depreciation
93.37
98.41
102.25
106.06
107.51
106.09
110.43
116.84
120.49
120.62
122.1
123.87
Profit Before Tax
53.89
34.62
107.27
18.46
22.81
130.68
312.34
224.22
269.73
326.56
361.37
481.36
Tax Paid
14.57
9.45
31.95
6.25
5.09
40.07
78.47
63.14
75.98
73.45
79.46
119.37
Profit After Tax
39.32
25.17
75.32
12.21
17.72
90.61
233.87
161.08
193.75
253.11
281.91
361.99
Total Net profit including share of profit / Loss from associate company
37.12
23.34
75.02
12.68
19.95
92.94
232.77
161.68
194.49
251.88
282.09
362.07
EPS
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
5.17
6.81
Actual EPS
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
5.17
6.81
Adjusted EPS
0.69
0.43
1.4
0.23
0.37
1.71
4.34
3.02
3.61
4.67
5.17
6.81
Diluted EPS
0.68
0.43
1.4
0.23
0.37
1.71
4.33
3.02
3.61
4.65
5.17
6.81

Laurus Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
2,056.17
2,291.92
2,831.72
4,813.51
4,935.57
6,040.55
5,040.83
5,553.96
6,812.9
Other Income
29.19
16.15
5.92
23.66
15.3
6
26.34
75.1
54.95
Total Income
2,085.36
2,308.07
2,837.64
4,837.17
4,950.87
6,046.55
5,067.17
5,629.06
6,867.85
Expenses
1,642.85
1,935.93
2,267.17
3,262.83
3,513.14
4,448.36
4,263.33
4,498.68
5,035.19
Operating Profit
413.32
355.99
564.55
1,550.68
1,422.43
1,592.19
777.5
1,055.28
1,777.71
Operating Profit Margin %
20.1%
15.53%
19.94%
32.22%
28.82%
26.36%
15.42%
19%
26.09%
Profit Before Interest, Tax and Depreciation
442.51
372.13
570.47
1,574.34
1,437.73
1,598.19
803.84
1,130.38
1,832.66
Interest
79.64
88.19
89.59
68.16
102.39
165.17
182.9
216
170.73
Depreciation
125.45
164.19
187.27
205.07
251.49
324.08
384.58
430.09
480.05
Profit Before Tax
237.42
119.75
293.61
1,301.11
1,083.85
1,108.94
236.36
484.29
1,181.88
Tax Paid
69.81
25.99
38.34
317.29
251.42
312.3
68.15
129.88
292.03
Profit After Tax
167.61
93.76
255.27
983.82
832.43
796.64
168.21
354.41
889.85
Total Net profit including share of profit / Loss from associate company
167.61
93.76
255.27
983.82
832.23
793.43
162.27
358.34
890.14
EPS
15.83
8.83
4.78
18.36
15.42
14.69
2.98
6.65
16.47
Actual EPS
15.83
8.83
4.78
18.36
15.42
14.69
2.98
6.65
16.47
Adjusted EPS
3.17
1.77
0.96
18.36
15.42
14.69
2.98
6.65
16.47
Diluted EPS
15.76
8.8
4.78
18.28
15.35
14.64
2.98
6.64
16.45

Laurus Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
181.97
331.99
342.49
297.66
347.42
733
911.1
993.9
665.69
601.65
1,623.5
Cash Flow from Investing Activities
-312.01
-288.76
-384.16
-252.93
-221.04
-940.93
-914.47
-996.94
-822.25
-680.33
-1,085.66
Cash Flow from Financing Activities
103.32
-53.61
42.25
-44.77
-127.66
254.7
30.26
-26.64
249.83
39.28
-524.72
Net Cash Flow
-26.72
-10.38
0.58
-0.04
-1.28
46.77
26.89
-29.68
93.27
-39.4
13.12

Laurus Labs Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
27.19%
27.19%
27.18%
27.18%
27.62%
27.62%
27.59%
27.59%
27.49%
27.49%
27.47%
DII
10.77%
11.77%
13.56%
13.05%
12.74%
11.77%
11.94%
11.73%
12.43%
13.97%
13.74%
FII
0%
25.97%
25.67%
26.08%
25.56%
25.52%
25.7%
26.16%
26.52%
25.82%
28%
Public
36.29%
35.07%
33.59%
33.69%
34.08%
35.09%
34.77%
34.51%
33.56%
32.71%
30.78%
Total Outstanding Shares
53,89,65,858
53,89,65,858
53,91,59,314
53,91,59,314
53,92,52,491
53,92,52,491
53,98,24,899
53,98,24,899
53,98,56,582
53,98,56,582
54,02,49,583
Total Shareholders
3,82,880
3,56,830
3,24,059
3,09,063
2,92,214
2,92,905
2,80,223
2,83,678
2,80,756
2,92,281
2,91,653

Mutual Funds Buying / Exiting Laurus Labs

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Laurus Labs

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Laurus Labs

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Mirae Asset ELSS Tax Saver Fund -Direct Plan-Growth

Mirae Asset ELSS Tax Saver Fund -Direct Plan-Growth

₹1,243.44 Cr

₹26.55 Cr (-2.09%)

4.56%

Mirae Asset Midcap Fund Direct Growth

Mirae Asset Midcap Fund Direct Growth

₹863.57 Cr

₹19.81 Cr (-2.24%)

4.12%

UTI Nifty200 Momentum 30 Index Fund Direct Growth

UTI Nifty200 Momentum 30 Index Fund Direct Growth

₹497.20 Cr

₹7.37 Cr (-1.46%)

5.95%

Laurus Labs Corporate Actions

View detailed summary of the earnings and dividend history of Laurus Labs.

  • Laurus Labs Ltd Earnings Results

    Laurus Labs Ltd’s net profit jumped 125.49% since last year same period to ₹367.60Cr in the Q1 2026-2027. On a quarterly growth basis, Laurus Labs Ltd has generated 31.69% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Laurus Labs Ltd Dividends April,2026

    In the quarter ending March 2026, Laurus Labs Ltd has declared dividend of ₹1.20 per share on 30 Apr 2026 - translating a dividend yield of 0.14%.

    Read More about Dividends

Indices Featuring Laurus Labs Stock

Check stock indices that include Laurus Labs.

S&P BSE 150 MidCap

₹16,497.82

+4.12 (▲0.02%)

Nifty 200

₹13,498.80

+56.55 (▲0.42%)

S&P BSE Momentum

₹2,150.92

+12.71 (▲0.59%)

S&P BSE 400 MidSmallCap

₹12,402.26

-4.58 (▲0.04%)

BSE Healthcare

₹50,347.94

-130.87 (▲0.26%)

S&P BSE 250 LargeMidCap

₹10,410.97

+40.45 (▲0.39%)

Nifty LargeMidcap 250

₹16,130.00

+42.55 (▲0.26%)

Nifty 500

₹22,554.10

+76.65 (▲0.34%)

Nifty Healthcare

₹16,249.40

-49.60 (▲0.30%)

Nifty Alpha 50

₹54,554.45

+67.55 (▲0.12%)

Nifty Midcap 150

₹22,359.20

+0.40 (▲0%)

Nifty Midcap 50

₹17,549.95

-6.40 (▲0.04%)

NIFTY PHARMA

₹26,107.35

-81.05 (▲0.31%)

S&P BSE MidCap Select

₹18,259.79

+1.27 (▲0.01%)

Nifty Midcap 100

₹60,864.60

-13.65 (▲0.02%)

Nifty MidSmallcap 400

₹20,737.75

-12.95 (▲0.06%)

BSE 500

₹35,285.83

+116.21 (▲0.33%)

Insights on Laurus Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 1.58K Cr → 2.03K Cr (in ₹), with an average increase of 6.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LAURUSLABS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, LAURUSLABS stock has moved up by 40.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LAURUSLABS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 25.82% to 28.00% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, 163.02 Cr → 367.6 Cr (in ₹), with an average increase of 18.2% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 27.49% to 27.47% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 11.22% to 10.15% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 32.71% to 30.78% in Jun 2026 quarter

Laurus Labs Stock Futures & Options Contracts

View the latest movement in Laurus Labs Futures & Options, including strike prices, expiry dates, and percentage changes.

Laurus Labs Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LAURUSLABS 29 Sep ₹2000 Call
September 29, 2026
₹2000
₹8.25
-6.25
-43.1%
LAURUSLABS 29 Sep ₹1940 Call
September 29, 2026
₹1940
₹19.1
-13
-40.5%
LAURUSLABS 29 Sep ₹1960 Call
September 29, 2026
₹1960
₹14
-10.65
-43.2%
LAURUSLABS 29 Sep ₹1900 Call
September 29, 2026
₹1900
₹32.95
-19.6
-37.3%

Laurus Labs Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LAURUSLABS 29 Sep Fut
September 29, 2026
-
₹1891.9
-36.64
-1.9%
LAURUSLABS 27 Oct Fut
October 27, 2026
-
₹1900
-38.38
-1.98%
LAURUSLABS 23 Nov Fut
November 23, 2026
-
₹1907.3
-40.12
-2.06%

About Laurus Labs Ltd

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in the production of generic active pharmaceutical ingredients (APIs) in high-growth therapeutic areas like antiretrovirals (ARVs), Hepatitis C, and Oncology. The company operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh, and has invested significantly in their RD and manufacturing infrastructure, having launched 59 products since its inception in 2005. Its key customers include Aspen Pharmacare Limited, Aurobindo Pharma Limited, Cipla Limited, Mylan Laboratories Limited, NATCO Pharma, Strides Shasun, among others. It has 34 owned patents plus 152 pending patent applications in various countries. It is increasingly focused on their integrated generics finished dosage forms FDFs business, having acquired of Sriam Labs and Richcore Lifesciences in the recent years. During 2020, it launched Hydroxychloroquine, initiated TLD supplies for the Global Fund tender, and bargained partnerships with various private and public organizations. On 2022, it infused capital in Laurus Generics Inc . and infused around Rs 46 crore to acquire a stake in Immunoadoptive Cell Therapy Private Limited, among other expansions and operations.

Revenue: ₹2,026.31Cr as on June 2026 (Q1 FY27)
Net Profit: ₹361.99Cr as on June 2026 (Q1 FY27)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
OrganisationLaurus Labs Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOM V G Rao
E-voting on sharesClick here to vote

FAQs

What is Laurus Labs share price today?

Laurus Labs share price today stands at ₹1878.5 as on . Laurus Labs share today touched a day high of ₹1940.4 and a low of ₹1863.5.

What is the 52 week high and 52 week low range for Laurus Labs share?

Laurus Labs touched a 52 week high of ₹1981.8 and a 52 week low of ₹823.1. Laurus Labs share price today i.e. is trending at ₹1878.5, which is -5.21% down from its 52 week high and 128.22% up from its 52 week low.

What is Laurus Labs's market capitalisation today?

Laurus Labs market capitalisation is ₹1,04,112.76 Cr as on .

How to buy Laurus Labs shares?

To buy Laurus Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LAURUSLABS or Laurus Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Laurus Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Laurus Labs trading volume today?

Laurus Labs trading volume is 20.33L as on . This means that 20.33L shares of Laurus Labs were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Laurus Labs shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Laurus Labs have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 22 days. This reflects platform activity only and is not investment advice.